Skip to main content

and
  1. Article

    Open Access

    Period of hospitalization and mortality in transferred versus non-transferred COVID-19 patients: results from Germany

    COVID-19 was a challenge for health-care systems worldwide, causing large numbers of hospitalizations and inter-hospital transfers. We studied whether transfer, as well as its reason, was associated with the d...

    Pascal Suski, Rudolf A. Jörres, Sebastian Engelhardt, Kathrin Kahnert in Scientific Reports (2024)

  2. Article

    Open Access

    Cardiovascular predictors of mortality and exacerbations in patients with COPD

    In chronic obstructive pulmonary disease (COPD), comorbidities and worse functional status predict worse outcomes, but how these predictors compare with regard to different outcomes is not well studied. We thu...

    Peter Alter, Tanja Lucke, Henrik Watz, Stefan Andreas in Scientific Reports (2022)

  3. Article

    Open Access

    Sex-specific associations of comorbidome and pulmorbidome with mortality in chronic obstructive pulmonary disease: results from COSYCONET

    In patients with COPD, it has not been comprehensively assessed whether the predictive value of comorbidities for mortality differs between men and women. We therefore aimed to examine sex differences of COPD ...

    Franziska C. Trudzinski, Rudolf A. Jörres, Peter Alter, Julia Walter in Scientific Reports (2022)

  4. Article

    Open Access

    Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment

    We studied whether in patients with COPD the use of metformin for diabetes treatment was linked to a pattern of lung function decline consistent with the hypothesis of anti-aging effects of metformin. Patients...

    Kathrin Kahnert, Stefan Andreas, Christina Kellerer in Scientific Reports (2022)

  5. Article

    Open Access

    Systemic inflammation and pro-inflammatory cytokine profile predict response to checkpoint inhibitor treatment in NSCLC: a prospective study

    Treatment with single agent immune checkpoint inhibitors (ICIs) has tremendously changed second line therapy in NSCLC. However, there are still no reliable biomarkers predicting response and survival in this g...

    Diego Kauffmann-Guerrero, Kathrin Kahnert, Rosemarie Kiefl in Scientific Reports (2021)